date,title,source
Oct-23-18,"Report: Exploring Fundamental Drivers Behind Corcept Therapeutics, News Corporation, Nightstar Therapeutics PLC Sponsored ADR, Rudolph Technologies, Applied Optoelectronics, and United Rentals  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-31-18,Is Corcept Therapeutics Incorporateds (NASDAQ:CORT) CEO Incentives Align With Yours?,Simply Wall St.
Nov-01-18,Corcept Therapeutics (CORT) Meets Q3 Earnings Estimates,Zacks
Nov-01-18,Corcept: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Corcept Therapeutics Announces Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Nov-05-18,"Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates",Zacks
Nov-14-18,Edited Transcript of CORT earnings conference call or presentation 1-Nov-18 9:00pm GMT,Thomson Reuters StreetEvents
Nov-19-18,Corcept Therapeutics Announces First Patient Dosed in Phase 3 Trial of Relacorilant to Treat Patients with Cushings Syndrome,GlobeNewswire
Nov-20-18,Corcept Initiates Phase III Study for Cushing's Syndrome,Zacks
Nov-26-18,What You Must Know About Corcept Therapeutics Incorporateds (NASDAQ:CORT) Financial Strength,Simply Wall St.
Nov-30-18,"Report: Exploring Fundamental Drivers Behind Tesla, Nordson, Paycom Software, PDL BioPharma, Corcept Therapeutics, and Willis Towers Watson Public  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Dec-11-18,Here's Why Corcept Therapeutics Surged Today,Motley Fool
Dec-11-18,Here's Why Corcept Therapeutics Rose 18.6% in November,Motley Fool
Dec-12-18,Today's Research Reports on Trending Tickers: MYOS RENS Technology and Corcept Therapeutics,ACCESSWIRE
Dec-13-18,Biotech Companies in the News,ACCESSWIRE
Dec-13-18,Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushings Syndrome,GlobeNewswire
